Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3709617019 | Product containing dinoprostone in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3709618012 | Dinoprostone-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing dinoprostone in oral dose form (medicinal product form) | Is a | Product containing dinoprostone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in oral dose form (medicinal product form) | Has active ingredient | Prostaglandin E>1< | false | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in oral dose form (medicinal product form) | Has active ingredient | Dinoprostone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing dinoprostone in oral dose form (medicinal product form) | Has active ingredient | Posterior pituitary hormone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in oral dose form (medicinal product form) | Has active ingredient | Alprostadil | false | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in oral dose form (medicinal product form) | Is a | Product manufactured as oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in oral dose form (medicinal product form) | Plays role | Oxytocic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely dinoprostone 500 microgram/1 each conventional release oral tablet | Is a | False | Product containing dinoprostone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only dinoprostone in oral dose form (medicinal product form) | Is a | True | Product containing dinoprostone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Dinoprostone 500micrograms tablet | Is a | False | Product containing dinoprostone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR